Evolus Inc . (NASDAQ:EOLS), a company specializing in aesthetic products with a market capitalization of $933 million, has recently made significant strides in expanding its product portfolio and ...
Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...
Q4 2024 Earnings Call Transcript February 13, 2025 IRadimed Corporation misses on earnings expectations. Reported EPS is ...
Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
The FTSE 100 and European stocks were mixed at the open on Monday, as traders digest the potential of escalating tensions ...
Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
As the market opens for a new trading day, here are some stocks that are in focus. From BHEL’s new contract to Glenmark ...
Q4 2024 Earnings Call Transcript February 13, 2025 GE HealthCare Technologies Inc. beats earnings expectations. Reported EPS is $1.45, expectations were $1.26. Operator: Good day, and thank you for ...
The FTSE 100 and European stocks were mixed at the open on Monday, as traders digest the potential of escalating tensions between European powers, Ukraine and Russia. London's pre ...
Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...
In today's stock market update for February 17, we highlight key stocks to watch: Wipro, which appointed Amit Kumar as Managing Partner and Global Head of Consulting; BHEL, which secured a Letter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results